Evaluation status available after sign-in
About the journal
Orphanet Journal of Rare Diseases is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,590 EUR. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1750-1172
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,590 EUR
- Articles in DOAJ
- 4333
- Declared review time
- 16 weeks
- Declared peer-review model
- other
- Official website
- https://ojrd.biomedcentral.com
Index listings
- DOAJ · 2006-03-03
- MEDLINE · 2006-01-01
- PUBMED · 2006-03-01
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,590 EUR
- Declared review time (DOAJ)
- 16 weeks
- Actual review time (measured)
- 172 days received→accepted — computed from PubMed (n=95)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
4333
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
5352
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
179
i10-index
2961
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2006-03-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 83%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- OJRD
- Source type
- journal
- NLM unique ID (PubMed)
- 101266602
- Society affiliations
- Orphanet
Classification2
Subjects (DOAJ)
Medicine
LCC codes
R
Subject areas
- Metabolism and Genetic Disorders
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Lysosomal Storage Disorders Research
- Lysosomal Storage Disorders Research
- Lysosomal Storage Disorders Research
- Glycogen Storage Diseases and Myoclonus
Show all subjects (75)
- Metabolism and Genetic Disorders
- Metabolism and Genetic Disorders
- Connective tissue disorders research
- Glycogen Storage Diseases and Myoclonus
- Glycogen Storage Diseases and Myoclonus
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Connective tissue disorders research
- Connective tissue disorders research
- Hereditary Neurological Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Neurogenetic and Muscular Disorders Research
- Neurogenetic and Muscular Disorders Research
- Mitochondrial Function and Pathology
- Mitochondrial Function and Pathology
- Genetic Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Neurogenetic and Muscular Disorders Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Genetic Neurodegenerative Diseases
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Genetics and Neurodevelopmental Disorders
- Pharmaceutical Economics and Policy
- Immunodeficiency and Autoimmune Disorders
- Hereditary Neurological Disorders
- Tuberous Sclerosis Complex Research
- Tuberous Sclerosis Complex Research
- Hereditary Neurological Disorders
- Genetic and rare skin diseases.
- Folate and B Vitamins Research
- Folate and B Vitamins Research
- Muscle Physiology and Disorders
- Skin and Cellular Biology Research
- Skin and Cellular Biology Research
- Tuberous Sclerosis Complex Research
- Cystic Fibrosis Research Advances
- Dermatological and Skeletal Disorders
- Cystic Fibrosis Research Advances
- Family and Disability Support Research
- Dermatological and Skeletal Disorders
- Genetic Syndromes and Imprinting
- Genetic Syndromes and Imprinting
- Muscle Physiology and Disorders
- Biomedical Research and Pathophysiology
- Cardiomyopathy and Myosin Studies
- Biomedical Research and Pathophysiology
- Autoimmune and Inflammatory Disorders Research
- Muscle Physiology and Disorders
- Autoimmune and Inflammatory Disorders Research
- Cardiomyopathy and Myosin Studies
- Vascular Malformations and Hemangiomas
- Amino Acid Enzymes and Metabolism
- Mitochondrial Function and Pathology
- Amyotrophic Lateral Sclerosis Research
- Genomic variations and chromosomal abnormalities
- Amyotrophic Lateral Sclerosis Research
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Skin and Cellular Biology Research
- Statistical Methods in Clinical Trials
- Neurological diseases and metabolism
- Genomic variations and chromosomal abnormalities
- Hemophilia Treatment and Research
- Cardiomyopathy and Myosin Studies
Keywords (DOAJ)
- rare diseases
- orphan drugs
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ